Good immune response from Covishield & Covaxin: Study
A ‘real-world’ study of vaccinated healthcare workers has found Covishield and Covaxin could produce a high immune response in up to 95% recipients and prevent serious disease in those infected after immunisation. Interestingly, the Oxford vaccine Covishield could generate antibodies in more individuals compared to Bharat Biotech’s Covaxin, a pre-print of the first such Indian study has stated. Most vaccine efficacy studies so far have been lab-based.
You Might Like
💡 newsR Knowledge: Other News Mentions
UK revises travel policy, implies issue is India's vaccine certificate | Covishield | Oneindia News
Credit: Oneindia Duration: 01:40Published
Covishield approved in UK, travel advisory revised after strong objections from IndiaThe UK has revised its vaccine policy for travelers from India, and Covishield jabs have been approved in the travel advisory.
India warns UK of reciprocal steps over vaccine ‘discrimination’“Covishield is a licensed product of the UK company, manufactured in India of which we have supplied five million doses to the UK,” said Shringla, pointing..
Covaxin supply to hit 5.5 cr doses from October: Bharat Biotech chairmanCovaxin output is all set to be ramped up to 5.5 crore doses in October from to 3.5 crore doses in September, Bharat Biotech’s chairman & managing director Dr..
Covaxin may soon get WHO approval as expert group scheduled to meet next monthSAGE members and Bharat Biotech officials will hold a meeting where safety and efficacy of Covaxin will be discussed on the basis trial data in India.
Covaxin may get WHO approval by month-end: NITI Aayog Member Dr VK PaulIndia's indigenously-developed Covid vaccine Covaxin may soon receive Emergency Use Listing by the World Health Organisation, eventually enabling its recipients..
Related videos from verified sources
Related news from verified sources